{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:19:25Z","timestamp":1760059165602,"version":"build-2065373602"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Autosomal recessive juvenile Parkinson disease (ARJP) is an early-onset neurodegenerative disorder characterized by Parkinsonian motor symptoms with slow progression and preserved cognition. Biallelic pathogenic variants within the PRKN gene are associated with ARJP. Among PRKN pathogenic variants, deletions are a frequent occurrence and may be identified through chromosomal microarray testing. Methods: Here we present a case with two intragenic PRKN deletions initially identified as a secondary finding using chromosomal microarray. One deletion was paternally inherited and the second initially appeared to be de novo. In addition to microarray which initially identified the two deletions, long-range GAP-PCR and Sanger sequencing were used to further characterize the de novo deletion and phase of the deletions. Results: Molecular characterization of the apparently de novo deletion demonstrated low-level maternal mosaicism of this deletion, thus proving that these deletions are in trans in the proband, yielding a diagnosis of autosomal recessive juvenile Parkinson disease. Conclusions: This case highlights the utility of a diagnostic approach combining microarray, long-range PCR, and Sanger sequencing to establish the phase and confirm biallelic PRKN deletions in a patient with ARJP. Furthermore, these findings highlight the importance of investigating the possibility of parental mosaicism to determine the phase of autosomal recessive variants and establish accurate recurrence risks.<\/jats:p>","DOI":"10.3390\/genes16060630","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:39:36Z","timestamp":1748205576000},"page":"630","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase Determination and Demonstration of Parental Mosaicism of Intragenic PRKN Deletions Initially Identified by Chromosomal Microarray Analysis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-0550","authenticated-orcid":false,"given":"Lauren A.","family":"Choate","sequence":"first","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Division of Cytogenetics, Center for Advanced Molecular Diagnostics, Department of Pathology, Harvard Medical School and Brigham and Women\u2019s Hospital, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica H.","family":"Newman","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-6385","authenticated-orcid":false,"given":"Cassandra","family":"Runke","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Webley","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Hoppman","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik C.","family":"Thorland","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","article-title":"Incidence of Parkinson disease in North America","volume":"8","author":"Willis","year":"2022","journal-title":"npj Parkinsons Disease"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","article-title":"Molecular genetics of Parkinson\u2019s disease: Contributions and global trends","volume":"68","author":"Funayama","year":"2023","journal-title":"J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","article-title":"Parkin disease: A clinicopathologic entity?","volume":"70","author":"Doherty","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson\u2019s disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.27352","article-title":"Genotype-Phenotype Relations for the Parkinson\u2019s Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review","volume":"33","author":"Kasten","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson\u2019s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson\u2019s Disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","article-title":"PRKN-linked familial Parkinson\u2019s disease: Cellular and molecular mechanisms of disease-linked variants","volume":"81","author":"Clausen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/hmg\/ddaa273","article-title":"Assessing the relationship between monoallelic PRKN mutations and Parkinson\u2019s risk","volume":"30","author":"Lubbe","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2021.12.014","article-title":"Genotype-phenotype correlation of Parkinson\u2019s disease with PRKN variants","volume":"114","author":"Yoshino","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awab456","article-title":"Heterozygous PRKN mutations are common but do not increase the risk of Parkinson\u2019s disease","volume":"145","author":"Zhu","year":"2022","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","article-title":"A structural variation reference for medical and population genetics","volume":"581","author":"Collins","year":"2020","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/gcc.10236","article-title":"Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer","volume":"38","author":"Denison","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.20234","article-title":"Distribution, type, and origin of Parkin mutations: Review and case studiesz","volume":"19","author":"Hedrich","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_18","unstructured":"Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J., Bird, T.D., Ledbetter, N., Mefford, H.C., and Smith, R.J. (1993). 17q12 Recurrent Duplication. GeneReviews(\u00ae), University of Washington."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10048-005-0017-x","article-title":"Early-onset Parkinson\u2019s disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil","volume":"7","author":"Chien","year":"2006","journal-title":"Neurogenetics"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Isaacs, D., Claassen, D., Bowman, A.B., and Hedera, P. (2017). Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations. Brain Sci., 7.","DOI":"10.3390\/brainsci7070071"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L","article-title":"Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype","volume":"48","author":"Klein","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","article-title":"Monogenic Parkinson\u2019s disease and parkinsonism: Clinical phenotypes and frequencies of known mutations","volume":"19","author":"Puschmann","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41531-022-00346-3","article-title":"Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions","volume":"8","author":"Cukier","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/318791","article-title":"Origin of the mutations in the parkin gene in Europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects","volume":"68","author":"Periquet","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/ene.15788","article-title":"Indication for molecular testing by multiplex ligation-dependent probe amplification in parkinsonism","volume":"30","author":"Mutez","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mgg3.482","article-title":"Molecular characterization of PRKN structural variations identified through whole-genome sequencing","volume":"6","author":"Bravo","year":"2018","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Trinh, J., Schaake, S., Gabbert, C., L\u00fcth, T., Cowley, S.A., Fienemann, A., Ullrich, K.K., Klein, C., and Seibler, P. (2024). Optical genome mapping of structural variants in Parkinson\u2019s disease-related induced pluripotent stem cells. BMC Genom., 25.","DOI":"10.1186\/s12864-024-10902-1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mgg3.386","article-title":"Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN","volume":"6","author":"Williams","year":"2018","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0004.2011.01693.x","article-title":"Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease","volume":"82","author":"Kim","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/mds.29610","article-title":"Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson\u2019s Disease","volume":"38","author":"Daida","year":"2023","journal-title":"Mov. Disord."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/630\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:39:52Z","timestamp":1760031592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["genes16060630"],"URL":"https:\/\/doi.org\/10.3390\/genes16060630","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2025,5,24]]}}}